Table 4.
Studies | Type of Study | Type of Auto-Antibodies | Study Group | Control Group | Clinical Pregnancy Rate | Live Birth/Ongoing Pregnancy Rate | Miscarriage Rate | |||
---|---|---|---|---|---|---|---|---|---|---|
Study Group | Control Group | Study Group | Control Group | Study Group | Control Group | |||||
Rogenhofer et al., 2015 [82] | Case Report | −AGA | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Subit et al., 2011 [83] | Prospective | −AEA | −AEA+ 296 Single IUI cycles 105 double IUI cycles |
AEA− 673 single IUI cycles 169 double IUI cycles |
4.01% 14.29% |
13.07% 16.57% |
n/a | n/a | n/a | n/a |
Zini et al., 2011 [91] | Prospective | −ASA | −26 ASA(+) Men | −225 ASA(−) Men | 42% | 52% | n/a | n/a | n/a | n/a |
Caccavo et al., 2011 [85] | Prospective | aLN-1 | −11 aLN-1 positive women with endometriosis | 24 aLN-1 negative women with endometriosis | n/a | n/a | 36% | 29% | n/a | n/a |
Sarapik et al., 2010 [86] | Not provided | −AEA | −190 AEA positive women | n/a | OR: IgA: 0.95 IgG: 1.00 a |
n/a | n/a | n/a | n/a | n/a |
Francavilla et al., 2009 [87] | Cross-Over | −ASA | −38 ASA positive men | −212 ASA negative OAT men | 19% (without COH) 17.6% (with COH) |
2.9% (without COH) 6.4% (with COH |
n/a | n/a | n/a | n/a |
Randall et al., 2009 [88] | Not provided | AEA | Not Provided b | |||||||
Van Weert et al., 2008 [89] | Prospective | ASA | −43 ASA positive men | −430 ASA negative men | 20.93% | 25.76% | n/a | n/a | n/a | n/a |
Esteves et al., 2007 [90] | Retrospective | −ASA | 17 men with 50% or more ASA | 301 men with 20% or less ASA | 47.06% | 53.16% | n/a | n/a | 25% | 17.94% |
a: The study provided only odds ratio for IgA and IgG, as well as certain molecular weight IgAs and IgGs; b:The raw data of the study could not be obtained. A total of 352 patients were included and miscarriage was higher in the AEA positive group.